Trends in Immunology

Papers
(The H4-Index of Trends in Immunology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Subscription and Copyright Information507
Advisory Board and Contents421
Subscription and Copyright Information413
Advisory Board and Contents231
Advisory Board and Contents206
Unleashing dendritic cell-mediated tumor clearance by targeting Bcl-2168
On tending sprouts: empowering emerging immunologists in Latin America165
Tensor-based insights into systems immunity and infectious disease165
‘Smelling’ lipid cues: chemosensory receptors tune tumor-associated macrophage behavior135
Contribution of gut-derived T cells to extraintestinal autoimmune diseases124
Metabolic and stress response adaptations in T cells to fever and physiological heat103
Type 2 conventional dendritic cell functional heterogeneity: ontogenically committed or environmentally plastic?97
Innate immunity: the bacterial connection95
Novel insights and recent progress in osteoimmunology91
DNA flexibility can shape the preferential hypermutation of antibody genes88
Dietary fibers affecting gastrointestinal immunity76
Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine74
Beyond the innate immune system: rethinking inflammasomes in multiple sclerosis71
DNA at the center of mammalian innate immune recognition of bacterial biofilms69
Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeutics69
Oxidative battles in tuberculosis: walking the ferroptotic tightrope68
Loss of ARID1A ‘loops’ in STING67
Subscription and Copyright Information64
EmBmem: will the real memory B cell please stand up?64
Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?61
Targeting WSTF degradation to resolve chronic inflammation61
BCR signaling in germinal center B cell selection54
Inflammatory and immune etiology of type 2 diabetes51
The tumor niche can reprogram long-lived protumorigenic neutrophils50
Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis50
Trained immunity-based mucosal immunotherapies for the prevention of respiratory infections49
Advisory Board and Contents48
Risk factors of cytokine release syndrome: stress, catecholamines, and beyond48
Infusion of neutralization into Lassa vaccine design48
Unanticipated specificity in effector-triggered immunity47
High endothelial venules as potential gateways for therapeutics46
Cytosolic delivery of innate immune agonists46
Agents of cancer immunosurveillance: HSPs and dsDNA45
Leveraging community engagement to shape biomedical research priorities45
Subscription and Copyright Information44
Genotype–phenotype landscapes for immune–pathogen coevolution44
Context-dependent regulation of follicular helper T cell survival43
The five senses of immunity42
0.096082925796509